ALB and neoplasm: Exploratory graphical analysis suggested that there was no trend between ivosidenib PK parameters and the continuous baseline characteristics of age, body weight, body mass index, markers of hepatic and renal function, use of CYP3A inducers/inhibitors, albumin, sex, ethnicity, race, tumor type, and performance status (data not shown).